Risperidone
Who holds supplier records for Risperidone? 22 organisations hold a current record for Risperidone: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 17 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (13), Spain (2), Netherlands (1), Italy (1) and 3 other countries (3); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Risperidone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/risperidone
Reading the evidence
- 22 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
13 of the 20 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 15 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Risperidone expires 17 Mar 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (22)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Risperidone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsCEPActive DMF 35434, 15604 · latest filing Apr 2021
- CHIERON ACTIVE INGREDIENTS PRIVATE LTDIndiaCEPActive DMF 35646 · latest filing Mar 2021
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 16963 · latest filing Nov 2003
- ICROM SRLItalyCEP Company GMP cert on recordActive DMF 35974, 25683 · latest filing Jun 2021
- INKE SASpainCEPActive DMF 15682 · latest filing Oct 2001
- Janssen Pharmaceutica NVBelgiumCEP Company GMP cert on recordActive DMF 11438 · latest filing Apr 1995
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 16517 · latest filing Apr 2003
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 17520 · latest filing Jul 2004
- Torrent PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 21630 · latest filing May 2008
- WUXI JIDA PHARMACEUTICAL CO LTDCEPActive DMF 25605 · latest filing Dec 2011
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 20518 · latest filing May 2007
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 18068 · latest filing Feb 2005
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 18120 · latest filing Feb 2005
- INTERQUIM SAPeru Company GMP cert on recordActive DMF 18257 · latest filing Apr 2005
- Ipca Laboratories LimitedIndia Company GMP cert on recordActive DMF 22911 · latest filing Jul 2009
- STHREE CHEMICALS PRIVATE LTDActive DMF 41579 · latest filing Jul 2025
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 21446 · latest filing Mar 2008
- IndiaCEP Company GMP cert on record
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordInactive DMF 16023 · latest filing Jun 2002
- Lupin LimitedIndiaCEP Company GMP cert on recordInactive DMF 19267 · latest filing Mar 2006
- MEDICHEM SASpainCEP Company GMP cert on recordInactive DMF 16516 · latest filing Apr 2003
- Rpg Life Sciences Ltd.IndiaCEP Company GMP cert on recordInactive DMF 22432 · latest filing Jan 2009
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (17)
Certificates of Suitability on the EDQM register for Risperidone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2009-243 - Rev 04 Risperidone, Form 1 | Aug 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2006-060 - Rev 08 Risperidone | May 2026 | — |
| CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad | IN | CEP 2018-210 - Rev 02 Risperidone | Dec 2025 | — |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2002-151 - Rev 08 Risperidone | Sept 2025 | — |
| ICROM S.R.L. Concorezzo | IT | CEP 2023-293 - Rev 00 Risperidone | Jul 2025 | Inspected Feb 2025 Italy |
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2024-147 - Rev 00 Risperidone | Jul 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2003-110 - Rev 06 Risperidone | Jul 2025 | — |
| TORRENT PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2004-160 - Rev 04 Risperidone | Jan 2025 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2005-037 - Rev 03 Risperidone | May 2024 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R1-CEP 2005-078 - Rev 02 Risperidone | Jul 2022 | — |
| WUXI JIDA PHARMACEUTICAL CO., LTD. Jiangyin | CN | R1-CEP 2012-264 - Rev 00 Risperidone | Feb 2019 | — |
| JANSSEN PHARMACEUTICA NV Beerse | BE | R1-CEP 2001-183 - Rev 05 Risperidone | Jan 2017 | — |
| LUPIN LIMITED Mumbai | IN | R1-CEP 2007-160 - Rev 01 Risperidone | Sept 2016 | — |
| RPG Life Sciences Limited Navi Mumbai | IN | R1-CEP 2004-135 - Rev 05 Risperidone | Oct 2015 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2006-308 - Rev 00 Risperidone | Oct 2013 | — |
| Medichem, S.A. Sant Joan Despí | ES | R1-CEP 2007-105 - Rev 00 Risperidone | Apr 2013 | — |
| INKE, S.A. Castellbisbal | ES | R1-CEP 2006-054 - Rev 00 Risperidone | Jul 2012 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Risperidone are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- China · Inactive DMF 24290, 25202 · filed Jul 2011
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 22853 · filed Jun 2009
- JIANGSU JIWA RINTECH PHARMACEUTICAL CO LTDInactive DMF 20656 · filed Jul 2007
- India · Inactive DMF 20409 · filed Mar 2007
- Italy · Inactive DMF 19370 · filed Apr 2006
- Hungary · Inactive DMF 18446 · filed Jun 2005
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (137 listed products contain Risperidone). The latest listed patent expires 17 Mar 2042. The latest listed exclusivity ended 12 May 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Risperidone is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and irritability associated with autistic disorder. It works by antagonizing dopamine D2 receptors and serotonin type 2A (5-HT2A) receptors in the brain.
Chemical identity
- IUPAC name
- 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
- Canonical SMILES
- CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
- InChIKey
- RAPZEAPATHNIPO-UHFFFAOYSA-N
- Synonyms
- Risperdal API, ly-03004, n05ax08, nsc-759895, perseris, r 64 766, r-64,766, r-64-766, r-64766, rcn-3028, rcn3028, risperdal
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Atypical Antipsychotic
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Risperidone?
22 organisations hold an active US FDA Type II Drug Master File or a CEP for Risperidone: TAPI NL BV (Netherlands), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (India), Cipla Limited (India), ICROM SRL (Italy), INKE SA (Spain), Janssen Pharmaceutica NV (Belgium), JUBILANT BIOSYS LTD (India) and MATRIX PHARMACORP PRIVATE LTD (India), and 14 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Risperidone Drug Master Files are active?
TAPI NL BV (DMF 35434, 15604), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (DMF 35646), Cipla Limited (DMF 16963), ICROM SRL (DMF 35974, 25683), INKE SA (DMF 15682), Janssen Pharmaceutica NV (DMF 11438), JUBILANT BIOSYS LTD (DMF 16517) and MATRIX PHARMACORP PRIVATE LTD (DMF 17520) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Risperidone records mean?
6 organisations have only inactive Type II DMFs for Risperidone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Risperidone have a European Certificate of Suitability?
Yes. 17 organisations hold a valid CEP for Risperidone on the EDQM register, including DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad (IN), JUBILANT BIOSYS LIMITED Nanjangud (IN), ICROM S.R.L. Concorezzo (IT) and AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN) and 11 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Risperidone?
Yes. The latest patent listed for an approved US product containing Risperidone expires 17 Mar 2042, across 137 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Risperidone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Risperidone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.